Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features
As Outset has added features improving Tablo since the FDA first cleared it for use, it has now had to submit another 510(k) application to the FDA, thus limiting sales to acute facilities only.
Read the full article » | Posted 07-13-2022
Related Articles
- Education Critical to Boosting Home Dialysis, Panel Says I Posted 01-16-2026
- The Annual Dialysis Conference Will be in Kansas City, MO February 26 to March 1 Posted 01-16-2026
- The Forum of ESRD Networks has New Videos for its 2023 Home Dialysis Toolkit Posted 01-16-2026
- Vantive: Real People, Real Stories on PD Empowers Site for Patients Posted 12-17-2025

